Editorial: Metabolic associated fatty liver disease: clinical perspectives from pathogenesis to diagnosis and treatment

Frontiers in Endocrinology

Endocrinology

Zhe Huang¹  Kenneth Kingyip Cheng²  Dewei Ye³  Kerry Loomes⁴  Hannah Xiaoyan Hui⁵ 

[1] Department of Genetics and Developmental Science, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China;Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, Hong Kong SAR, China;Key Laboratory of Metabolic Phenotyping in Model Animals, Guangdong Pharmaceutical University, Guangzhou, China;School of Biological Sciences and Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand;School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China;

关键词: MAFLD;    obesity;    biological marker;    calcium signalling;    metabolic disorders;   

DOI  :  10.3389/fendo.2023.1206642

 received in 2023-04-16, accepted in 2023-06-21,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Huang, Ye, Loomes, Cheng and Hui